These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

859 related items for PubMed ID: 15900021

  • 1. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
    Nakamura Y, Ono H, Zhou X, Frohlich ED.
    Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 4. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H, Ono Y, Frohlich ED.
    Hypertension; 1996 Feb 15; 27(2):176-83. PubMed ID: 8567038
    [Abstract] [Full Text] [Related]

  • 5. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM.
    Clin Sci (Lond); 2006 Feb 15; 110(2):227-33. PubMed ID: 16197366
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
    Miloradović Z, Jovović D, Mihailović-Stanojević N, Milanović JG, Milanović S.
    Can J Physiol Pharmacol; 2008 Apr 15; 86(4):210-4. PubMed ID: 18418431
    [Abstract] [Full Text] [Related]

  • 7. N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    J Hypertens; 2002 May 15; 20(5):993-1000. PubMed ID: 12011661
    [Abstract] [Full Text] [Related]

  • 8. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.
    Ono Y, Ono H, Frohlich ED.
    J Hypertens; 1996 Jul 15; 14(7):823-8. PubMed ID: 8818920
    [Abstract] [Full Text] [Related]

  • 9. Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME.
    Francischetti A, Ono H, Frohlich ED.
    Hypertension; 1998 Mar 15; 31(3):795-801. PubMed ID: 9495263
    [Abstract] [Full Text] [Related]

  • 10. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM, Robertson SJ, Burns KD, deBlois D.
    Hypertens Res; 2012 Jun 15; 35(6):604-10. PubMed ID: 22318205
    [Abstract] [Full Text] [Related]

  • 11. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1997 Dec 15; 122(7):1385-94. PubMed ID: 9421286
    [Abstract] [Full Text] [Related]

  • 12. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2004 Dec 15; 24(2):242-9. PubMed ID: 15031627
    [Abstract] [Full Text] [Related]

  • 13. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS, Clark KL, Johns EJ, Drew GM.
    Br J Pharmacol; 1998 Aug 15; 124(7):1467-74. PubMed ID: 9723960
    [Abstract] [Full Text] [Related]

  • 14. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA, Paffaro VA, Pauli JR, da Silva GH, Saad MJ, Salgado I, da Cruz-Höfling MA, Hyslop S.
    Cell Tissue Res; 2007 Jul 15; 329(1):45-58. PubMed ID: 17436021
    [Abstract] [Full Text] [Related]

  • 15. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kramer HJ, Horacek V, Bäcker A, Vaneckova I, Heller J.
    Kidney Blood Press Res; 2004 Jul 15; 27(1):10-7. PubMed ID: 14583658
    [Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin II type-1 receptor blocker losartan on age-related cardiovascular risk in spontaneously hypertensive rats.
    Mihailović-Stanojević N, Miloradović Z, Grujić-Milanović J, Ivanov M, Jovović D.
    Gen Physiol Biophys; 2009 Jul 15; 28 Spec No():112-8. PubMed ID: 19893088
    [Abstract] [Full Text] [Related]

  • 17. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N, Khang S, Wead LM, Blantz RC, Gabbai FB.
    Am J Kidney Dis; 2002 Jan 15; 39(1):159-64. PubMed ID: 11774115
    [Abstract] [Full Text] [Related]

  • 18. Renoprotective effects of omapatrilat are mediated partially by bradykinin.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2003 Jan 15; 23(4):214-21. PubMed ID: 12789027
    [Abstract] [Full Text] [Related]

  • 19. NO-independent mechanism mediates tempol-induced renal vasodilation in SHR.
    de Richelieu LT, Sorensen CM, Holstein-Rathlou NH, Salomonsson M.
    Am J Physiol Renal Physiol; 2005 Dec 15; 289(6):F1227-34. PubMed ID: 16033921
    [Abstract] [Full Text] [Related]

  • 20. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation.
    Fanelli C, Fernandes BH, Machado FG, Okabe C, Malheiros DM, Fujihara CK, Zatz R.
    Am J Physiol Renal Physiol; 2011 Sep 15; 301(3):F580-7. PubMed ID: 21653629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.